Post-engraftment, sorted hCD45+ cells derived at diagnosis exhibited three major AML mutational compositions: EZH2, EZH2+IDH1, and TP53+NPM1 (Figure 5A,B). This evidence concerns the gene TP53 and acute myeloid leukemia.